A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Incyte Corporation
Incyte Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Janssen Research & Development, LLC
J-Pharma Co., Ltd.
Bristol-Myers Squibb
Hoffmann-La Roche
Bristol-Myers Squibb
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
AstraZeneca
Incyte Corporation
MedImmune LLC
Hoffmann-La Roche
Jiangsu HengRui Medicine Co., Ltd.
GlaxoSmithKline
Cardiff Oncology
Incyte Corporation
Mirror Biologics, Inc.
ITM Solucin GmbH
NovaOnco Therapeutics Co., Ltd.
Leap Therapeutics, Inc.
Lisata Therapeutics, Inc.
Inspirna, Inc.
Biotheus Inc.
Alethia Biotherapeutics
Bristol-Myers Squibb
Merus B.V.
Eli Lilly and Company
Sichuan Baili Pharmaceutical Co., Ltd.
iOMEDICO AG
Lipomedix Pharmaceuticals Inc.
Genentech, Inc.
WntResearch AB
Amgen
Celyad Oncology SA
Celyad Oncology SA
Eli Lilly and Company
MedImmune LLC
Mereo BioPharma
Sirtex Medical
Eli Lilly and Company
Eli Lilly and Company
Merck Sharp & Dohme LLC
ERYtech Pharma
IntegraGen SA
Genentech, Inc.
AstraZeneca
AstraZeneca
Genentech, Inc.
Shenzhen Hornetcorn Bio-technology Company, LTD
Shenzhen Hornetcorn Bio-technology Company, LTD